Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE) is a monoclonal antibody targeting GPC3 (glypican-3). It induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth and can be used in the research of hepatocellular carcinoma (HCC). MW :145.58 KD.

• Supplier: Selleck Chemicals
• Product #: A3151
• Sku #: A3151-1mg